Back
Wells Fargo Lifts BBIO Target to $88 on Drug Revenue Beat
Back
Stock News
Themes
Wells Fargo Lifts BBIO Target to $88 on Drug Revenue Beat
Wells Fargo Lifts BBIO Target to $88 on Drug Revenue Beat
Edgen Stock
·
Jan 23 2026, 20:26
Share to
Share to
Copy link
WFC
+0.94%
BBIO
-2.53%
source:
[1] Wells Fargo Remains a Buy on BridgeBio Pharma (BBIO)
Recommend
Apple Stock Climbs as Investors Shun Big Tech's $650B AI Spending
Feb 18 2026, 00:32
Similarweb Swings to Profit, Beating Q4 Estimates
Feb 17 2026, 23:58
Hormel Sells Turkey Business, Reaffirms 2026 Guidance
Feb 17 2026, 23:57
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Edgen Stock·Jan 23 2026, 20:26Edgen Stock·Jan 23 2026, 20:26
Edgen Stock·Jan 23 2026, 20:26